Ningbo MedicalSystem Return On Equity vs. Profit Margin
| 300439 Stock | 11.61 0.11 0.96% |
For Ningbo MedicalSystem profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Ningbo MedicalSystem to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Ningbo MedicalSystem Biotechnology utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Ningbo MedicalSystem's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Ningbo MedicalSystem Biotechnology over time as well as its relative position and ranking within its peers.
Ningbo |
Ningbo MedicalSystem Profit Margin vs. Return On Equity Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Ningbo MedicalSystem's current stock value. Our valuation model uses many indicators to compare Ningbo MedicalSystem value to that of its competitors to determine the firm's financial worth. Ningbo MedicalSystem Biotechnology is number one stock in return on equity category among its peers. It also is number one stock in profit margin category among its peers fabricating about 1.48 of Profit Margin per Return On Equity. Comparative valuation analysis is a catch-all model that can be used if you cannot value Ningbo MedicalSystem by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Ningbo MedicalSystem's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Ningbo Profit Margin vs. Return On Equity
Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Ningbo MedicalSystem |
| = | 0.0933 |
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Ningbo MedicalSystem |
| = | 0.14 % |
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
Ningbo Profit Margin Comparison
Ningbo MedicalSystem is currently under evaluation in profit margin category among its peers.
Ningbo MedicalSystem Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Ningbo MedicalSystem, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Ningbo MedicalSystem will eventually generate negative long term returns. The profitability progress is the general direction of Ningbo MedicalSystem's change in net profit over the period of time. It can combine multiple indicators of Ningbo MedicalSystem, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Operating Income | 253 M | 283.2 M | |
| Income Before Tax | 295.7 M | 184.2 M | |
| Net Income Applicable To Common Shares | 178.7 M | 91.6 M | |
| Net Income | 256.6 M | 139 M | |
| Income Tax Expense | 20.8 M | 19.8 M | |
| Net Income From Continuing Ops | 259.5 M | 145 M | |
| Total Other Income Expense Net | 544.2 K | 571.4 K | |
| Net Interest Income | 2.4 M | 2.5 M | |
| Interest Income | 13.3 M | 13.9 M | |
| Change To Netincome | 117.4 M | 196.4 M |
Ningbo Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Ningbo MedicalSystem. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Ningbo MedicalSystem position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Ningbo MedicalSystem's important profitability drivers and their relationship over time.
Use Ningbo MedicalSystem in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Ningbo MedicalSystem position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ningbo MedicalSystem will appreciate offsetting losses from the drop in the long position's value.Ningbo MedicalSystem Pair Trading
Ningbo MedicalSystem Biotechnology Pair Trading Analysis
The ability to find closely correlated positions to Ningbo MedicalSystem could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Ningbo MedicalSystem when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Ningbo MedicalSystem - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Ningbo MedicalSystem Biotechnology to buy it.
The correlation of Ningbo MedicalSystem is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Ningbo MedicalSystem moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Ningbo MedicalSystem moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Ningbo MedicalSystem can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Ningbo MedicalSystem position
In addition to having Ningbo MedicalSystem in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Penny Thematic Idea Now
Penny
Solid stocks, funds or ETFs with below average market capitalization and typicl daily price below 2. The Penny theme has 56 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Penny Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Ningbo Stock
To fully project Ningbo MedicalSystem's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Ningbo MedicalSystem at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Ningbo MedicalSystem's income statement, its balance sheet, and the statement of cash flows.